These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18985031)

  • 1. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.
    Mi Z; Guo H; Russell MB; Liu Y; Sullenger BA; Kuo PC
    Mol Ther; 2009 Jan; 17(1):153-61. PubMed ID: 18985031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.
    Talbot LJ; Mi Z; Bhattacharya SD; Kim V; Guo H; Kuo PC
    Surgery; 2011 Aug; 150(2):224-30. PubMed ID: 21801960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R; Kumar V; Lohite K; Karnik S; Kundu GC
    Carcinogenesis; 2010 Feb; 31(2):192-200. PubMed ID: 19926637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.
    Hunter C; Bond J; Kuo PC; Selim MA; Levinson H
    J Surg Res; 2012 Jul; 176(1):348-58. PubMed ID: 21962803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
    Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
    Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis.
    Mi Z; Bhattacharya SD; Kim VM; Guo H; Talbot LJ; Kuo PC
    Carcinogenesis; 2011 Apr; 32(4):477-87. PubMed ID: 21252118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
    Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC
    Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
    Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
    Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
    Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
    Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
    Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
    BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
    Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
    Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
    Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An MAPK-dependent pathway induces epithelial-mesenchymal transition via Twist activation in human breast cancer cell lines.
    Li NY; Weber CE; Wai PY; Cuevas BD; Zhang J; Kuo PC; Mi Z
    Surgery; 2013 Aug; 154(2):404-10. PubMed ID: 23889968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
    Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
    Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.